These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9113835)
1. Changes in symptomatology, hormones, lipids, and bone density after hysterectomy. Carranza-Lira S; Murillo-Uribe A; Martínez Trejo N; Santos-González J Int J Fertil Womens Med; 1997; 42(1):43-7. PubMed ID: 9113835 [TBL] [Abstract][Full Text] [Related]
2. Changes in symptoms, blood pressure, glucose, hormones, and lipid levels according to weight and body fat distribution in climacteric women. Carranza-Lira S; Murillo-Uribe A; Martínez-Trejo N; Santos-González J Int J Fertil Womens Med; 1998; 43(6):306-11. PubMed ID: 9920540 [TBL] [Abstract][Full Text] [Related]
3. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women]. Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849 [TBL] [Abstract][Full Text] [Related]
4. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia. Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207 [TBL] [Abstract][Full Text] [Related]
5. Serum lipid levels in women with premature ovarian failure. Gulhan I; Bozkaya G; Uyar I; Oztekin D; Pamuk BO; Dogan E Menopause; 2012 Nov; 19(11):1231-4. PubMed ID: 22713860 [TBL] [Abstract][Full Text] [Related]
6. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M; Fait T; Kovar J; Poledne R; Ceska R Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386 [TBL] [Abstract][Full Text] [Related]
7. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women. Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373 [TBL] [Abstract][Full Text] [Related]
9. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Komesaroff PA; Black CV; Cable V; Sudhir K Climacteric; 2001 Jun; 4(2):144-50. PubMed ID: 11428178 [TBL] [Abstract][Full Text] [Related]
10. Lipid profile of women with premature ovarian failure. Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT Menopause; 2008; 15(5):919-23. PubMed ID: 18551082 [TBL] [Abstract][Full Text] [Related]
11. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study]. Grisar J; Travica S; Metka M; Pietschmann P Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891 [TBL] [Abstract][Full Text] [Related]
13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524 [TBL] [Abstract][Full Text] [Related]
14. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children. Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339 [TBL] [Abstract][Full Text] [Related]
15. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women. Hudita D; Posea C; Ceausu I; Rusu M Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586 [TBL] [Abstract][Full Text] [Related]
17. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. The Women's Health in the Lund Area (WHILA) study. Nerbrand C; Lidfeldt J; Nyberg P; Scherstén B; Samsioe G Maturitas; 2004 Jun; 48(2):161-9. PubMed ID: 15172091 [TBL] [Abstract][Full Text] [Related]
18. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
19. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
20. Association between serum cholesterol and bone mineral density. Makovey J; Chen JS; Hayward C; Williams FM; Sambrook PN Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]